{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:16:55Z","timestamp":1773047815887,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T00:00:00Z","timestamp":1648339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck &amp; Co Inc","doi-asserted-by":"publisher","award":["58824"],"award-info":[{"award-number":["58824"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P33546"],"award-info":[{"award-number":["P33546"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.antiviral.2022.105299","type":"journal-article","created":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T11:50:59Z","timestamp":1648381859000},"page":"105299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Reliable quantification of Cytomegalovirus DNAemia in Letermovir treated patients"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-7896","authenticated-orcid":false,"given":"Stefan","family":"Weinberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3500-7205","authenticated-orcid":false,"given":"Christoph","family":"Steininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105299_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1371\/journal.pone.0232571","article-title":"Methods to prevent PCR amplification of DNA from non-viable virus were not successful for infectious laryngotracheitis virus","volume":"15","author":"Bindari","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105299_bib2","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2022.105299_bib3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2147\/IDR.S180908","article-title":"Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review","volume":"12","author":"El Helou","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.antiviral.2022.105299_bib4","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1128\/JVI.05265-11","article-title":"The novel anticytomegalovirus compound AIC246 (letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase","volume":"85","author":"Goldner","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105299_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/cis900","article-title":"An international multicenter performance analysis of cytomegalovirus load tests","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105299_bib6","series-title":"The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation","author":"Kotton","year":"2018"},{"key":"10.1016\/j.antiviral.2022.105299_bib7","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/cid\/cis212","article-title":"Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective","volume":"54","author":"Kraft","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105299_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/femsre\/fuy004","article-title":"The human cytomegalovirus terminase complex as an antiviral target: a close-up view","volume":"42","author":"Ligat","year":"2018","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2022.105299_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e3181ff8719","article-title":"The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response","volume":"91","author":"Lisboa","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2022.105299_bib10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246","volume":"54","author":"Lischka","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2022.105299_bib11","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105299_bib12","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/ajt.15764","article-title":"Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation","volume":"20","author":"Marty","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2022.105299_bib13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/jvi.68.2.1040-1051.1994","article-title":"Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer","volume":"68","author":"McVoy","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105299_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijfoodmicro.2015.02.012","article-title":"Application of viability PCR to discriminate the infectivity of hepatitis A virus in food samples","volume":"201","author":"Moreno","year":"2015","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.antiviral.2022.105299_bib15","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1128\/JCM.38.9.3249-3253.2000","article-title":"False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation","volume":"38","author":"Sch\u00e4fer","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105299_bib16","article-title":"Letermovir for the compassionate therapeutic use of cytomegalovirus infection","author":"Schubert","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105299_bib17","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/JVI.02307-10","article-title":"A 128-base-pair sequence containing the pac1 and a presumed cryptic pac2 sequence includes cis elements sufficient to mediate efficient genome maturation of human cytomegalovirus","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:35:04Z","timestamp":1759062904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354222000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":17,"alternative-id":["S0166354222000687"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105299","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reliable quantification of Cytomegalovirus DNAemia in Letermovir treated patients","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105299"}}